Controversies in the Management of Papillary Thyroid Cancer Revisited
ISRN Oncology · 2011
DOI: 10.5402/2011/303128 ↗Kurz gefasst
Fachartikel in der Zeitschrift ISRN Oncology, 2011. Verfasst von Marlon A Guerrero und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, University of Arizona, 1501 N. Campbell Avenue, P.O. Box 245131, Tucson, AZ 85724, USA. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0).
Abstract (Originalsprache)
The debate on the appropriate treatment of patients with papillary thyroid cancer (PTC) has persisted for several decades. The main controversies focus on the extent of surgery, the timing of central neck dissection, and the indications for radioactive iodine ablation. These controversies continue, for the most part, due to the good prognosis of PTC patients and the questionable effect these treatment modalities have on patient survival. This paper addresses these three controversies and the role of molecular tumor markers in the appropriate treatment selection.
Autor:innen und Institutionen
- Department of Surgery, University of Arizona, 1501 N. Campbell Avenue, P.O. Box 245131, Tucson, AZ 85724, USA.
Zitieren
APA
Guerrero, M. A., & Clark, O. H. (2011). Controversies in the Management of Papillary Thyroid Cancer Revisited. ISRN Oncology. https://doi.org/10.5402/2011/303128
Vancouver
Guerrero MA, Clark OH. Controversies in the Management of Papillary Thyroid Cancer Revisited. ISRN Oncology. 2011. doi:10.5402/2011/303128
BibTeX
@article{Guerrero2011,
author = {Guerrero, Marlon A and Clark, Orlo H},
title = {Controversies in the Management of Papillary Thyroid Cancer Revisited},
journal = {ISRN Oncology},
year = {2011},
doi = {10.5402/2011/303128}
}
EUVIMED